Refile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Wed 15:19
REFILE-BRIEF-Umecrine Cognition Gets Notice Of Allowance In US Adds missing second bullet point
Oct 21 (Reuters) - Kdventures AB KDV.ST:
PORTFOLIO CO UMECRINE COGNITION GETS NOTICE OF ALLOWANCE FROM UNITED STATES PATENT AND TRADEMARK OFFICE FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) SYMPTOMS WITH GOLEXANOLONE
PATENT EXPECTED TO PROVIDE US PROTECTION UNTIL AT LEAST 2042
Source text: ID:nMFNbP9q4F
Further company coverage: KDV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Kdventures AB
See all newsRefile: BRIEF-Umecrine Cognition Gets Notice Of Allowance In US
Brief: KDventures' Modus Therapeutics Pauses Enrollment In Phase 2A Study
Brief: KDventures' AnaCardio Raises €62.5 Million
Brief: Kdventures' Umecrine Cognition Gets Two USPTO Notices Of Allowance For Patent Applications
Brief: Kdventures' Modus Therapeutics Carries Out Directed Issue